rpx7009 has been researched along with Disease-Models--Animal* in 1 studies
1 other study(ies) available for rpx7009 and Disease-Models--Animal
Article | Year |
---|---|
Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.
The recently approved combination of meropenem and vaborbactam (Vabomere) is highly active against Gram-negative pathogens, especially Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Disease Models, Animal; Drug Combinations; Escherichia coli; Humans; Klebsiella pneumoniae; Meropenem; Mice; Microbial Sensitivity Tests; Pyelonephritis; Urinary Tract Infections | 2018 |